Oruka Therapeutics, Inc.
Current- Director 2026 to present
Skip to record
Executive record
Alpha ID: alpha:person:paul-quinlanVersion: public-0As of: 2026-10-03
Not yet claimed9 published Claims4 sources
- Director
- Counsel
Leadership, in context.
Connect capital, control, accountability, and evidence.
Explore the record
ResponsibilitiesInspect board appointments and committee mandates.ExperienceReview career history and qualifications in context.Economic interestsExamine disclosed incentives and ownership.Key Claims
Biography
Paul Quinlan is named as a proxy appointee for the 2026 Annual Meeting of Stockholders, indicating an executive officer role at Oruka Therapeutics, Inc. No further biographical details are provided in this filing section.
Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.
Board service
Boards
Claims
Executive career
- Current · dates not publishedGeneral Counsel and Corporate Secretary · Oruka Therapeutics, Inc.
- 2026 to end not publishedExecutive title: Executive Officer · Organization not publishedORKA DEF 14A executive officers
- Dates not publishedExecutive title: General Counsel and Corporate Secretary · Organization not published
Claims
Compensation
Compensation coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageConflicts and accountability
Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.
Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.
Evidence, history and coverage
Additional published Claims
Published evidence records
4 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
ORKA DEF 14A executive officers
sec filing · Source published: Apr 17, 2026 · Retrieved: May 5, 2026
Supports 5 claims
- AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 5, 2026
- Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 5, 2026
- Executive company: Executive at Oruka Therapeutics, Inc. · Claim reviewed: May 5, 2026
- Executive title: Executive title: Executive Officer · Claim reviewed: May 5, 2026
- Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 5, 2026
Open source
sec proxy · Source published: Apr 17, 2026 · Retrieved: Sep 2, 2026
Supports 1 claim
- Professional Role: Director at Oruka Therapeutics, Inc. · Claim reviewed: Sep 12, 2026
Open source
sec def 14a · Source published: Apr 17, 2026 · Retrieved: Sep 12, 2026
Supports 2 claims
- Professional Role: General Counsel and Corporate Secretary at Oruka Therapeutics, Inc. · Claim reviewed: Sep 12, 2026
- Executive title: Executive title: General Counsel and Corporate Secretary · Claim reviewed: Sep 12, 2026
Open source
public source · Source published: Date unavailable · Retrieved: Date unavailable
Supports 1 claim
- Board membership: Serves on the board of Oruka Therapeutics, Inc. · Claim reviewed: Sep 12, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
source reported
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-10-03
- Biography
- published
- Board service
- published
- Executive career
- published
- Education and qualifications
- not observed
- Compensation
- not observed
- Conflicts and accountability
- not observed
- Background screening
- out of scope